FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2094587965> ?p ?o ?g. }

• W2094587965 endingPage "1252" @default.
• W2094587965 startingPage "1249" @default.
• W2094587965 abstract "A novel series of selective negative allosteric modulators (NAMs) for metabotropic glutamate receptor 5 (mGlu5) was discovered from an isothiazole scaffold. One compound of this series, (1R,2R)-N-(4-(6-isopropylpyridin-2-yl)-3-(2-methyl-2H-indazol-5-yl)isothiazol-5-yl)-2-methylcyclopropanecarboxamide (24), demonstrated satisfactory pharmacokinetic properties and, following oral dosing in rats, produced dose-dependent and long-lasting mGlu5 receptor occupancy. Consistent with the hypothesis that blockade of mGlu5 receptors will produce analgesic effects in mammals, compound 24 produced a dose-dependent reduction in paw licking responses in the formalin model of persistent pain." @default.
• W2094587965 created "2016-06-24" @default.
• W2094587965 creator A5015871920 @default.
• W2094587965 creator A5021793950 @default.
• W2094587965 creator A5025270598 @default.
• W2094587965 creator A5030233254 @default.
• W2094587965 creator A5031219597 @default.
• W2094587965 creator A5038227968 @default.
• W2094587965 creator A5039400744 @default.
• W2094587965 creator A5040843846 @default.
• W2094587965 creator A5043297436 @default.
• W2094587965 creator A5050707771 @default.
• W2094587965 creator A5057615631 @default.
• W2094587965 creator A5057928180 @default.
• W2094587965 creator A5059041675 @default.
• W2094587965 creator A5060626649 @default.
• W2094587965 creator A5064451475 @default.
• W2094587965 creator A5070729673 @default.
• W2094587965 creator A5072749828 @default.
• W2094587965 creator A5074035943 @default.
• W2094587965 creator A5074380938 @default.
• W2094587965 creator A5077473953 @default.
• W2094587965 creator A5086799646 @default.
• W2094587965 creator A5088874254 @default.
• W2094587965 creator A5090364105 @default.
• W2094587965 creator A5048331194 @default.
• W2094587965 date "2013-03-01" @default.
• W2094587965 modified "2023-10-18" @default.
• W2094587965 title "Discovery of (1R,2R)-N-(4-(6-isopropylpyridin-2-yl)-3-(2-methyl-2H-indazol-5-yl)isothiazol-5-yl)-2-methylcyclopropanecarboxamide, a potent and orally efficacious mGlu5 receptor negative allosteric modulator" @default.
• W2094587965 cites W1519706104 @default.
• W2094587965 cites W1970192153 @default.
• W2094587965 cites W1972498750 @default.
• W2094587965 cites W1978890358 @default.
• W2094587965 cites W1981597626 @default.
• W2094587965 cites W1984680586 @default.
• W2094587965 cites W1986434830 @default.
• W2094587965 cites W2019658937 @default.
• W2094587965 cites W2023882395 @default.
• W2094587965 cites W2042688106 @default.
• W2094587965 cites W2051857972 @default.
• W2094587965 cites W2065399310 @default.
• W2094587965 cites W2068273333 @default.
• W2094587965 cites W2076697810 @default.
• W2094587965 cites W2089862357 @default.
• W2094587965 cites W2106807118 @default.
• W2094587965 cites W2110212187 @default.
• W2094587965 cites W2116365861 @default.
• W2094587965 cites W2124955976 @default.
• W2094587965 cites W2154889119 @default.
• W2094587965 cites W2319201633 @default.
• W2094587965 doi "https://doi.org/10.1016/j.bmcl.2013.01.009" @default.
• W2094587965 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23374867" @default.
• W2094587965 hasPublicationYear "2013" @default.
• W2094587965 type Work @default.
• W2094587965 sameAs 2094587965 @default.
• W2094587965 citedByCount "10" @default.
• W2094587965 countsByYear W20945879652013 @default.
• W2094587965 countsByYear W20945879652014 @default.
• W2094587965 countsByYear W20945879652016 @default.
• W2094587965 countsByYear W20945879652017 @default.
• W2094587965 countsByYear W20945879652018 @default.
• W2094587965 countsByYear W20945879652019 @default.
• W2094587965 countsByYear W20945879652020 @default.
• W2094587965 countsByYear W20945879652022 @default.
• W2094587965 countsByYear W20945879652023 @default.
• W2094587965 crossrefType "journal-article" @default.
• W2094587965 hasAuthorship W2094587965A5015871920 @default.
• W2094587965 hasAuthorship W2094587965A5021793950 @default.
• W2094587965 hasAuthorship W2094587965A5025270598 @default.
• W2094587965 hasAuthorship W2094587965A5030233254 @default.
• W2094587965 hasAuthorship W2094587965A5031219597 @default.
• W2094587965 hasAuthorship W2094587965A5038227968 @default.
• W2094587965 hasAuthorship W2094587965A5039400744 @default.
• W2094587965 hasAuthorship W2094587965A5040843846 @default.
• W2094587965 hasAuthorship W2094587965A5043297436 @default.
• W2094587965 hasAuthorship W2094587965A5048331194 @default.
• W2094587965 hasAuthorship W2094587965A5050707771 @default.
• W2094587965 hasAuthorship W2094587965A5057615631 @default.
• W2094587965 hasAuthorship W2094587965A5057928180 @default.
• W2094587965 hasAuthorship W2094587965A5059041675 @default.
• W2094587965 hasAuthorship W2094587965A5060626649 @default.
• W2094587965 hasAuthorship W2094587965A5064451475 @default.
• W2094587965 hasAuthorship W2094587965A5070729673 @default.
• W2094587965 hasAuthorship W2094587965A5072749828 @default.
• W2094587965 hasAuthorship W2094587965A5074035943 @default.
• W2094587965 hasAuthorship W2094587965A5074380938 @default.
• W2094587965 hasAuthorship W2094587965A5077473953 @default.
• W2094587965 hasAuthorship W2094587965A5086799646 @default.
• W2094587965 hasAuthorship W2094587965A5088874254 @default.
• W2094587965 hasAuthorship W2094587965A5090364105 @default.
• W2094587965 hasConcept C112705442 @default.
• W2094587965 hasConcept C155647269 @default.
• W2094587965 hasConcept C166342909 @default.
• W2094587965 hasConcept C170493617 @default.
• W2094587965 hasConcept C185592680 @default.
• W2094587965 hasConcept C26702167 @default.
• W2094587965 hasConcept C2776038425 @default.
• W2094587965 hasConcept C2780723003 @default.

• next